Physician profile
Kanwaldeep Kaur
NPI 1578165528
$960.40
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $169 · 2022: $771 · 2023: $20.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $311.46 | 2022 | |
| Urovant Sciences INC | $93.59 | 2022 | |
| Novo Nordisk INC | $71.61 | 2021-2022 | |
| Lilly USA, LLC | $70.59 | 2021-2022 | |
| Abbvie INC. | $45.95 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $38.14 | 2021 | |
| Amarin Pharma, INC. | $36.05 | 2022 | |
| Amgen INC. | $35.30 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.32 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $32.99 | 2022 | |
| Alexion Pharmaceuticals, INC. | $28.23 | 2022 | |
| Pfizer INC. | $20.00 | 2023 | |
| Nestle Healthcare Nutrition INC. | $18.05 | 2022 | |
| Genentech USA, INC. | $16.34 | 2021 | |
| Corcept Therapeutics | $16.02 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $15.22 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.16 | 2021 | |
| Vivus LLC | $13.62 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $13.17 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $12.64 | 2022 | |
| Currax Pharmaceuticals LLC | $11.74 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $11.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kanwaldeep Kaur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.